16-74713369-G-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_024306.5(FA2H):​c.*821C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00276 in 152,354 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0028 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0033 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

FA2H
NM_024306.5 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.452

Publications

0 publications found
Variant links:
Genes affected
FA2H (HGNC:21197): (fatty acid 2-hydroxylase) This gene encodes a protein that catalyzes the synthesis of 2-hydroxysphingolipids, a subset of sphingolipids that contain 2-hydroxy fatty acids. Sphingolipids play roles in many cellular processes and their structural diversity arises from modification of the hydrophobic ceramide moiety, such as by 2-hydroxylation of the N-acyl chain, and the existence of many different head groups. Mutations in this gene have been associated with leukodystrophy dysmyelinating with spastic paraparesis with or without dystonia.[provided by RefSeq, Mar 2010]
FA2H Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 35
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-74713369-G-C is Benign according to our data. Variant chr16-74713369-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 320470.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00276 (420/152354) while in subpopulation NFE AF = 0.00288 (196/68046). AF 95% confidence interval is 0.00255. There are 3 homozygotes in GnomAd4. There are 208 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FA2HNM_024306.5 linkc.*821C>G 3_prime_UTR_variant Exon 7 of 7 ENST00000219368.8 NP_077282.3 Q7L5A8-1
FA2HXM_011523319.3 linkc.*821C>G 3_prime_UTR_variant Exon 7 of 7 XP_011521621.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FA2HENST00000562145.1 linkn.1661C>G non_coding_transcript_exon_variant Exon 2 of 2 1
FA2HENST00000219368.8 linkc.*821C>G 3_prime_UTR_variant Exon 7 of 7 1 NM_024306.5 ENSP00000219368.3 Q7L5A8-1
FA2HENST00000567683.5 linkn.*1219C>G downstream_gene_variant 2 ENSP00000455126.1 H3BP32

Frequencies

GnomAD3 genomes
AF:
0.00276
AC:
420
AN:
152236
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00137
Gnomad ASJ
AF:
0.0256
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00640
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00288
Gnomad OTH
AF:
0.00430
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00331
AC:
1
AN:
302
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
200
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
4
American (AMR)
AF:
0.00
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2
European-Finnish (FIN)
AF:
0.00649
AC:
1
AN:
154
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
10
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
100
Other (OTH)
AF:
0.00
AC:
0
AN:
28
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.00276
AC:
420
AN:
152354
Hom.:
3
Cov.:
33
AF XY:
0.00279
AC XY:
208
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.000625
AC:
26
AN:
41584
American (AMR)
AF:
0.00137
AC:
21
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0256
AC:
89
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00208
AC:
10
AN:
4818
European-Finnish (FIN)
AF:
0.00640
AC:
68
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00288
AC:
196
AN:
68046
Other (OTH)
AF:
0.00426
AC:
9
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
22
45
67
90
112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00270
Hom.:
0
Bravo
AF:
0.00253

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 35 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
2.5
DANN
Benign
0.72
PhyloP100
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs573058036; hg19: chr16-74747267; API